ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen " Phagenesis CEO Hoskins on helping stroke survivors recover; How Distalmotion will target ASCs "
Episode Synopsis
In this episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker tackle some of the weeks’ biggest news including the FDA giving a nod to Distalmotion’s Dexter robot and the Yankees blowing the World Series.
Distalmotion CEO Greg Roche visits to share his thoughts on both. Then Tom interviews Chad Hoskins, CEO of Phagenesis, a startup developing a neurostimulation device that could help stroke survivors recover.
This week’s Newmaker’s Newsmakers include Medtronic, Masimo, Exactech, Solventum and you already know about this week’s number one.
This episode is sponsored by DeviceTalks Boston. Register now at Boston.DeviceTalks.com.
Thanks for listening to this episode of the DeviceTalks Weekly Podcast.
Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.
More episodes of the podcast DeviceTalks Podcast Network
J&J’s Schmid, Stanford’s Makower on helping MedTech find a higher gear for innovation and growth
21/11/2025
How Enovis is accelerating orthopedic recovery with bone stimulation and patient-centered innovation
18/11/2025
Noah Medical’s clear vision for pulmonary bronchoscopy; FOMO: The true costs of MedTech tariffs
14/11/2025
Reimagining GI with AI: Olympus’ Blended Intelligence Approach to Burnout Relief & Patient Safety
11/11/2025
Medtronic’s Kowal describes an exciting future and new applications for cardiac pacing devices
07/11/2025
How Abbott is rethinking heart failure management through smarter monitoring and long-term support
27/10/2025
In God we trust